Leukoplakia: Difference between revisions
Ahmed Younes (talk | contribs) |
Ahmed Younes (talk | contribs) |
||
Line 52: | Line 52: | ||
Oral leukoplakia must be differentiated from other mouth lesions such as oral candidiasis and aphthous ulcer | Oral leukoplakia must be differentiated from other mouth lesions such as oral candidiasis and aphthous ulcer | ||
<div style="width: 70%;"> | <div style="width: 70%;"> | ||
<small><small> | <small><small> | ||
Line 170: | Line 169: | ||
*Can spread to [[TMJ]] | *Can spread to [[TMJ]] | ||
*Some times associated with [[leukoplakia]] | *Some times associated with [[leukoplakia]] | ||
|[[File: | |[[File:PLoS oral cancer.png|thumb|400x400px| |Squamous cell carcinoma - By Luca Pastore, Maria Luisa Fiorella, Raffaele Fiorella, Lorenzo Lo Muzio - http://www.plosmedicine.org/article/showImageLarge.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed.0050212.g001, CC BY 2.5, https://commons.wikimedia.org/w/index.php?curid=15252632]] | ||
|- | |- | ||
|[[Leukoplakia]] | |[[Leukoplakia]] | ||
Line 203: | Line 202: | ||
| pmid = 24113312 | | pmid = 24113312 | ||
}}</ref> | }}</ref> | ||
|[[File:Oral hairy leukoplakia (EBV, in HIV)a.jpg| | |[[File:Oral hairy leukoplakia (EBV, in HIV)a.jpg|thumb|400x300px|Leukoplakia - By Aitor III - Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=9873087]] | ||
|- | |- | ||
|[[Melanoma]] | |[[Melanoma]] | ||
Line 234: | Line 233: | ||
*Progression involves [[MAPK/ERK pathway]] | *Progression involves [[MAPK/ERK pathway]] | ||
*[[RAS|N-RAS]] or [[BRAF]] [[oncogene]] also involved | *[[RAS|N-RAS]] or [[BRAF]] [[oncogene]] also involved | ||
|[[File: | |[[File:Palate malign melanoma 01.jpg|thumb|400x400px|Oral melanoma - By Emmanouil K Symvoulakis, Dionysios E Kyrmizakis, Emmanouil I Drivas, Anastassios V Koutsopoulos, Stylianos G Malandrakis, Charalambos E Skoulakis and John G Bizakis - Symvoulakis et al. Head & Face Medicine 2006 2:7 doi:10.1186/1746-160X-2-7 (Open Access), [1], CC BY-SA 2.0, https://commons.wikimedia.org/w/index.php?curid=9839811]] | ||
|- | |- | ||
|[[Fordyce spots]] | |[[Fordyce spots]] | ||
Line 263: | Line 262: | ||
*No surrounding [[mucosal]] change | *No surrounding [[mucosal]] change | ||
*Several adjacent [[glands]] may coalesce into a larger cauliflower-like cluster | *Several adjacent [[glands]] may coalesce into a larger cauliflower-like cluster | ||
|[[File: | |[[File:Fospot.jpg|thumb|400x400px|Fordyce spots - Por Perene - Obra do próprio, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=19772899]] | ||
|- | |- | ||
|[[Burning mouth syndrome]] | |[[Burning mouth syndrome]] | ||
Line 307: | Line 306: | ||
*Repeated [[trauma]] can cause [[bleeding]] | *Repeated [[trauma]] can cause [[bleeding]] | ||
*[[Surgery]] may be required in symptomatic | *[[Surgery]] may be required in symptomatic | ||
|[[File:06-06-06palataltoria.jpg|Torus palatinus|400x400px]] | |[[File:06-06-06palataltoria.jpg|thumb|Torus palatinus|400x400px|Torus palatinus - By Photo taken by dozenist, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=846591]] | ||
|- | |- | ||
| colspan="4" |'''Diseases involving oral cavity and other organ systems''' | | colspan="4" |'''Diseases involving oral cavity and other organ systems''' | ||
Line 340: | Line 339: | ||
*[[Outbreaks]] of exaggerated [[inflammation]] | *[[Outbreaks]] of exaggerated [[inflammation]] | ||
*Affects smaller [[blood vessels]] | *Affects smaller [[blood vessels]] | ||
|[[File: | |[[File:Behcets disease.jpg|thumb|400x400px|Behcet's disease - By Ahmet Altiner MD, Rajni Mandal MD - http://dermatology.cdlib.org/1611/articles/18_2009-10-20/2.jpg, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=17863021]] | ||
|- | |- | ||
|[[Crohn's disease]] | |[[Crohn's disease]] | ||
Line 440: | Line 439: | ||
**[[Gumma|Gummas]] | **[[Gumma|Gummas]] | ||
**[[Neurosyphilis]] | **[[Neurosyphilis]] | ||
|[[File: | |[[File:Hutchinson teeth congenital syphilis PHIL 2385.rsh.jpg|thumb|400x400px|oral syphilis - By CDC/Susan Lindsley - http://phil.cdc.gov/phil_images/20021114/34/PHIL_2385_lores.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=2134349]] | ||
|- | |- | ||
|[[Coxsackie virus]] | |[[Coxsackie virus]] | ||
Line 472: | Line 471: | ||
*[[Pregnancy]] | *[[Pregnancy]] | ||
*[[Premature infants]] born to susceptible mothers | *[[Premature infants]] born to susceptible mothers | ||
*All [[infants]] born at less than 28 weeks [[gestation]] or who weigh | *All [[infants]] born at less than 28 weeks [[gestation]] or who weigh =1000 grams | ||
*[[Immunocompromised]] | *[[Immunocompromised]] | ||
| | | | ||
Line 484: | Line 483: | ||
*[[Paracetamol]] ([[acetaminophen]]) for [[fever]] | *[[Paracetamol]] ([[acetaminophen]]) for [[fever]] | ||
*[[Prednisolone]] is [[contraindicated]] | *[[Prednisolone]] is [[contraindicated]] | ||
|[[File: | |[[File:Herpangina2016.jpg|thumb|400x400px|Chickenpox - By James Heilman, MD - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=52872565]] | ||
|- | |- | ||
|[[Measles]] | |[[Measles]] | ||
Line 517: | Line 516: | ||
*Primary site of infection is the [[respiratory epithelium]] of the [[nasopharynx]] | *Primary site of infection is the [[respiratory epithelium]] of the [[nasopharynx]] | ||
*Transmitted in [[respiratory secretions]], via [[aerosol droplets]] containing [[Virus|virus particles]] | *Transmitted in [[respiratory secretions]], via [[aerosol droplets]] containing [[Virus|virus particles]] | ||
|[[File: | |[[File:Koplik spots, measles 6111 lores.jpg|thumb|400x400px|Koplick spots (Measles) - By CDC - http://phil.cdc.gov/PHIL_Images/20040908/4f54ee8f0e5f49f58aaa30c1bc6413ba/6111_lores.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=824483]] | ||
|}</small></small> | |}</small></small> | ||
</div> | </div> |
Latest revision as of 21:34, 13 September 2017
Template:DiseaseDisorder infobox
WikiDoc Resources for Leukoplakia |
Articles |
---|
Most recent articles on Leukoplakia Most cited articles on Leukoplakia |
Media |
Powerpoint slides on Leukoplakia |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Leukoplakia at Clinical Trials.gov Clinical Trials on Leukoplakia at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Leukoplakia
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Leukoplakia Discussion groups on Leukoplakia Patient Handouts on Leukoplakia Directions to Hospitals Treating Leukoplakia Risk calculators and risk factors for Leukoplakia
|
Healthcare Provider Resources |
Causes & Risk Factors for Leukoplakia |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Overview
Leukoplakia is a condition of the mouth that involves the formation of white leathery spots on the mucous membranes of the tongue and inside of the mouth. It is not a specific disease entity and is diagnosed by exclusion of diseases that may cause similar white lesions like candidiasis or lichen planus.
Epidemiology and Demographics
Leukoplakia affects less than one percent of the population, and is most common in adults within the 50-70 years age group.
Diagnosis
Common Causes
The cause in most cases is unknown, but many are related to tobacco use and chronic irritation. Bloodroot, otherwise known as sanguinaria, is also believed to be associated with causing leukoplakia.[1] A small proportion of cases, particularly those involving the floor of the mouth or the undersurface of the tongue is associated with a risk of cancer.
The so-called hairy leukoplakia associated with HIV infection and other diseases of severe immune deficiency does not have risks for cancer.
Physical Examination
Ear Nose and Throat
Vulvar leukoplakia
-
Vulvar leukoplakia. Adapted from Dermatology Atlas.[2]
-
Vulvar leukoplakia. Adapted from Dermatology Atlas.[2]
Differential diagnosis
Oral leukoplakia must be differentiated from other mouth lesions such as oral candidiasis and aphthous ulcer
Disease | Presentation | Risk Factors | Diagnosis | Affected Organ Systems | Important features | Picture |
---|---|---|---|---|---|---|
Diseases predominantly affecting the oral cavity | ||||||
Oral Candidiasis |
|
|
|
Localized candidiasis
Invasive candidasis |
|
|
Herpes simplex oral lesions |
|
|
|
|
||
Aphthous ulcers |
|
|
|
|
|
|
Squamous cell carcinoma |
|
|
||||
Leukoplakia |
|
|
|
|
||
Melanoma |
|
|
|
|
||
Fordyce spots |
|
|
|
|
||
Burning mouth syndrome |
|
|
||||
Torus palatinus |
|
|||||
Diseases involving oral cavity and other organ systems | ||||||
Behcet's disease |
|
|
|
|||
Crohn's disease |
|
|
|
|||
Agranulocytosis |
|
|
||||
Syphilis[5] |
|
|
|
|||
Coxsackie virus |
|
|
||||
Chicken pox |
|
|
|
|
||
Measles |
|
|
|
Treatment
The treatment of leukoplakia mainly involves avoidance of predisposing factors like smoking, tobacco and betel chewing, alcohol,and removal of chronic irritants like sharp edges of teeth. In suspicious cases, a biopsy is also taken, and surgical excision done if pre-cancerous changes or frank cancer is detected.
References
- ↑ Leukoplakia, (pdf format) hosted by the American Academy of Oral and Maxillofacial Pathology. Page accessed on December 19, 2006.
- ↑ 2.0 2.1 "Dermatology Atlas".
- ↑ Ann M. Gillenwater, Nadarajah Vigneswaran, Hanadi Fatani, Pierre Saintigny & Adel K. El-Naggar (2013). "Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!". Advances in anatomic pathology. 20 (6): 416–423. doi:10.1097/PAP.0b013e3182a92df1. PMID 24113312. Unknown parameter
|month=
ignored (help) - ↑ Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). "Idiosyncratic drug-induced agranulocytosis: Update of an old disorder". Eur J Intern Med. 17 (8): 529–35. Text "pmid 17142169" ignored (help)
- ↑ title="By Internet Archive Book Images [No restrictions], via Wikimedia Commons" href="https://commons.wikimedia.org/wiki/File:A_manual_of_syphilis_and_the_venereal_diseases%2C_(1900)_(14595882378).jpg"
- ↑ Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE (2000). "Individual and community risks of measles and pertussis associated with personal exemptions to immunization". JAMA. 284 (24): 3145–50. PMID 11135778.
- ↑ Ratnam S, West R, Gadag V, Williams B, Oates E (1996). "Immunity against measles in school-aged children: implications for measles revaccination strategies". Can J Public Health. 87 (6): 407–10. PMID 9009400.